Let-7b expression determines response to chemotherapy through the regulation of Cyclin D1 in Glioblastoma

BACKGROUND: Glioblastoma is the most common type of primary brain tumors. Cisplatin is a commonly used chemotherapeutic agent for Glioblastoma patients. Despite a consistent rate of initial responses, cisplatin treatment often develops chemoresistance, leading to therapeutic failure. Cellular resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yong, Yan, Kuipo, Fang, Jiasheng, Qu, Qiang, Zhou, Ming, Chen, Fenghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716992/
https://www.ncbi.nlm.nih.gov/pubmed/23806108
http://dx.doi.org/10.1186/1756-9966-32-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716992/
https://www.ncbi.nlm.nih.gov/pubmed/23806108
http://dx.doi.org/10.1186/1756-9966-32-41

Ejemplares similares